Pharma Laenen SRL
Pharma Laenen reported total assets of 64,760 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026).
The score of Pharma Laenen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -53 % Total assets -45 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Laenen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Pharma Laenen's financial analysis
- Solvency74.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Laenen
Pharma Laenen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0721.972.681
- VAT number
- BE0721972681
- Peppol
- Registered · 0208:0721972681 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Mar 2019
- Registered office
- 2440 Geel
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Laenen (SRL) has been based in Geel since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 9,012 € and equity of 48,469 €; its revenue is not published. Its solvency stands at 74.8%, above the median of its sector (44.2%).
Companies similar to Pharma Laenen
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Dorothee Vandevenne Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 64,554 €
- Paula Cosmina Retail sale of pharmaceutical products Ganshoren · balance sheet 64,266 €
- TV Retail sale of pharmaceutical products Haacht · balance sheet 65,446 €
- Liscicom Retail sale of pharmaceutical products Bruges · balance sheet 63,926 €
- Beukeleirs Holding Retail sale of pharmaceutical products Vielsalm · balance sheet 66,647 €
- Niemegeers Karolien Retail sale of pharmaceutical products Bonheiden · balance sheet 61,719 €
- Pharmacien Independant Pierre Burniaux Retail sale of pharmaceutical products Philippeville · balance sheet 61,668 €
Frequently asked questions about Pharma Laenen
What is the revenue of Pharma Laenen?
Pharma Laenen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Laenen?
In Belgium, the VAT number is the company number prefixed with BE: BE0721972681 for Pharma Laenen, if the company is VAT-registered. Its company number (CBE) is 0721.972.681.
Where is the registered office of Pharma Laenen?
According to the CBE register, the registered office of Pharma Laenen is in 2440 Geel.
What is the equity of Pharma Laenen?
At the close of the 2025 financial year, the equity of Pharma Laenen amounts to 48,469 €, a solvency of 74.8% of total assets.
Who manages Pharma Laenen?
The register lists 1 active mandates at Pharma Laenen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Laenen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →